Knowledge builds confidence.
Confidence empowers decisions.
Make It Make Sense (MIMS) is here to help you understand clinical trials and explore your options so you can have more informed conversations and make decisions that are right for you.
This Months Focus
This Month’s Focus
What Is HER2-Positive Early Breast Cancer?
Every person’s diagnosis is unique, and understanding your specific subtype can help inform conversations about treatment options, including clinical trials.
HER2-positive breast cancer is a type of breast cancer in which cancer cells produce higher-than-normal amounts of the HER2 protein. While HER2-positive cancers tend to grow and spread faster than other subtypes, advances in targeted therapies have improved outcomes for many patients.
Treatment options may include:
Surgery | Chemotherapy (when appropriate) | HER2-targeted therapies | Radiation therapy | Ongoing follow-up care
Why Are Clinical Trials Important?
Clinical trials help researchers discover new ways to:
Clinical trials are an important option for many people and may be available at different stages of breast cancer.
Our Promise
MIMS is designed to provide clear, unbiased educational information about clinical trials so you can have informed conversations with your healthcare team.
“Participation in a clinical trial is always your choice.”
Featured Clinical Trial Opportunities
These studies are currently enrolling individuals who may qualify. Talk with your healthcare team to determine whether participation may be right for you.
BC-303 (EmpowHER-303) Study
BC-208 (EmpowHER-208) Study
Talk with your healthcare team to see if a clinical trial may be right for you.
More About Clinical Trials →
Explore Trusted Resources
Start here to learn more about HER2-positive early breast cancer and clinical trial options.
Sponsored by
Tigerlily Foundation thanks Jazz Pharmaceuticals for their support of the Make It Make Sense (MIMS) initiative. Their partnership helps expand patient education and clinical trial awareness so more women can access the information they need to make empowered decisions.